Global Cough Syrup Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Cough Syrup Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Cough is a defensive reflex that occurs when the respiratory system is stimulated. A slight cough can clear sputum and foreign bodies in the trachea, and it can be relieved naturally. Generally, no cough medicine is needed. Strong and frequent cough, especially dry cough, may worsen the condition and cause complications. Use cough medicine. Cough syrup is mainly used for cough and phlegm elimination. For colds, cough, phlegm, bronchial asthma, etc. Cough syrup is a prescription drug.

Market Overview:

The latest research study on the global Cough Syrup market finds that the global Cough Syrup market reached a value of USD 3681.93 million in 2022. It’s expected that the market will achieve USD 4389.7 million by 2028, exhibiting a CAGR of 2.97% during the forecast period.

Drivers

Increased air pollution and rising prevalence of chronic respiratory diseases
Chronic respiratory disease has become a major global public health problem, with respiratory diseases accounting for 3 of the top five leading causes of death. Especially for low- and middle-income countries, loose environmental regulatory mechanisms have also caused serious air pollution. With the development of global industrialization, the pollution of industry to the environment has become increasingly serious. According to the International Respiratory Society Forum (FIRS) report, tobacco smoke, indoor air pollution from burning fuels, and air pollution from transportation and industrial sources are highlighted as the main contributors to most breathing conditions.
Long-term exposure to indoor smoke for heating and cooking can cause COPD, lung cancer, and cause pneumonia and asthma in children. A large population of respiratory diseases caused by air pollution is driving the cough syrup market as it is an important medicine for treating such diseases.
Increasing Geriatric Population
According to data from the United Nations' World Population Outlook: Revised 2019, by 2050, one in four people in Europe and North America will be 65 or older. In 2018, the world's population aged 65 or over has unprecedentedly exceeded the number of people under the age of 5. With the aging of the population, the population of the elderly is increasing, and the health problems of the elderly are gradually being taken seriously. The health of the elderly is very closely related to drugs. It can be said that the elderly is susceptible to the respiratory tract and some chronic diseases because they do not have strong immunity. And compared to young people, the cycle is relatively long. The aging population will provide a more stable downstream market for Cough Syrup Market.

Restraints

Although cough syrup is our common drug that can be easily purchased in pharmacies, it is also strictly regulated by the national pharmaceutical department for the raw material purchase, manufacturing, and sales pricing of cough syrup. Because cough medicines contain some poisonous ingredients, they are strictly controlled during the production process. In addition, because cough syrup contains ephedrine and other ingredients, cough syrup is strictly prohibited in the United Kingdom, the United States, Canada and other countries. Therefore, for manufacturers, strict regulations will hinder the market when conducting international trade.

Region Overview:

In 2022, the share of the Cough Syrup market in Asia-Pacific stood at 44.69%.

Company Overview:

Pfizer, Inc. is one of the major players operating in the Cough Syrup market, holding a share of 9.71% in 2023.

Pfizer, Inc.

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.

GlaxoSmithKline

GlaxoSmithKline PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.

Segmentation Overview:

Among different product types, Cough Suppressants segment is anticipated to contribute the largest market share in 2028.

Application Overview:

The market's largest segment by application is the segment Children, with a market share of 66.17% in 2022.

Key Companies in the global Cough Syrup market covered in Chapter 3:

GlaxoSmithKline
Pfizer
Johnson & Johnson
Abbott
Reckitt Benckiser
Acella Pharmaceuticals
Sanofi
Procter & Gamble

In Chapter 4 and Chapter 14.2, on the basis of types, the Cough Syrup market from 2018 to 2029 is primarily split into:

Cough Suppressants
Expectorants

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Cough Syrup market from 2018 to 2029 covers:

Adult
Children

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)